Browse studies
Find your next paid study
3 recruiting studies matching your filters
Observational
Evaluating the Impact of Autoimmune Protocol Diet on Proteinuria in Patients With IgA Nephropathy
This study at UCLA Center for Health Sciences is testing whether the Autoimmune Protocol (AIP) diet can lower protein levels in the urine of people with IgA Ne…
IgA Nephropathy (IgAN)
University of California, Los AngelesNCT07022574
Phase 2
A Phase 2 Study to Assess ADX-038 in Participants With Complement-Mediated Kidney Disease
This Phase 2 study is designed to assess the safety, efficacy, pharmacokinetics (PK) and pharmacodynamics (PD) of ADX-038 in adults with complement-mediated ki…
IgANC3GComplement-mediated Kidney Disease+2 more
ADARx Pharmaceuticals, Inc.NCT06989359
Phase 2
A Multi-Center, Phase II, Open Label, Randomized Trial Evaluating the Efficacy and Safety of Complement 5a Receptor Antagonist Avacopan in Crescentic IgA Nephropathy
The purpose of this study is to evaluate the efficacy and safety of Avacopan together with low-dose glucocorticoid in the treatment of patients with crescentic…
IgA Nephropathy (IgAN)
Mayo ClinicNCT06676579